Skip to content

The study of phototherapy with probiotics to treat jaundice in premature infants.

The study of phototherapy with probiotics to treat jaundice in premature infants.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-14005502
Enrollment
Unknown
Registered
2014-11-13
Start date
2013-12-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature infant jaundice

Interventions

Phototherapy (blue light):Phototherapy (blue light)
Phototherapy (blue light) and Bifid Triple Viable Capsules:Phototherapy (blue light) and Bifid Triple Viable Capsules
Phototherapy (blue light) and Saccharomyces boulardii Sachets:Phototherapy (blue light) and Saccharomyces boulardii Sachets

Sponsors

Affiliated Haikou Hospital of Xiangya Medical School Central South University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age: from premature birth to 28 days; 2. Newborns of gestational age less than 37 weeks; 3. The seventh edition of the Practical of Neonatology diagnosis standard of pathological jaundice: (1) Concentration of serum total bilirubin (TSB) more than at least 220.5 umol/L in full term, (TSB) more than 257 umol/L in preterm neonates; (2) The jaundice within 24 hours after birth; (3) Serum total bilirubin concentration increase more than 85.5umol/L (5mg/dl) every day or more than 8.5umol/L every hour; (4) Combining with the bilirubin more than 25.6 umol/L(1.5mg/dl); (5) Jaundice does not fade. Pathological jaundice can be considered in any item above.

Exclusion criteria

Exclusion criteria: (1) With severe immune deficiency; (2) Have a central venous catheter infusion; (3) Application of antifungal drugs during hospitalization; (4) Allergic to any medication; (5) Dropped out.

Design outcomes

Primary

MeasureTime frame
Bilirubin concentration;Phototherapy time;

Countries

China

Contacts

Public ContactJun Lu
Lu139762@163.com+86 13976240518

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026